Tatsuro Ishibashi Selected Research

coomassie Brilliant Blue

10/2013	Clinical evaluation and feasibility of changing intraoperative visibility with a novel viewing filter system for human eye.
12/2011	Critical involvement of extracellular ATP acting on P2RX7 purinergic receptors in photoreceptor cell death.
9/2011	Morphologic and functional advantages of macular hole surgery with brilliant blue G-assisted internal limiting membrane peeling.
7/2006	Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsuro Ishibashi Research Topics

Disease

39	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2018 - 03/2002
22	Macular Degeneration (Age-Related Maculopathy) 01/2021 - 09/2003
18	Inflammation (Inflammations) 01/2020 - 01/2003
18	Macular Edema 01/2020 - 06/2002
17	Uveitis 05/2018 - 09/2003
17	Choroidal Neovascularization 03/2018 - 09/2003
17	Retinal Perforations 01/2017 - 07/2006
14	Retinal Detachment (Retinal Detachments) 03/2018 - 03/2002
11	Retinitis Pigmentosa (Pigmentary Retinopathy) 10/2019 - 11/2008
11	Epiretinal Membrane (Epiretinal Membranes) 01/2016 - 03/2003
10	Proliferative Vitreoretinopathy 01/2017 - 06/2002
9	Polypoidal Choroidal Vasculopathy 05/2021 - 06/2004
8	Cataract (Cataracts) 10/2020 - 12/2007
8	Retinal Degeneration 01/2018 - 05/2002
7	Retinal Neovascularization 03/2017 - 01/2003
7	Neoplasms (Cancer) 10/2016 - 11/2005
6	Retinal Diseases 03/2017 - 06/2002
6	Glaucoma 04/2014 - 07/2002
6	Endophthalmitis (Ophthalmia) 06/2011 - 11/2003
5	Fibrosis (Cirrhosis) 03/2018 - 12/2003
5	Hemorrhage 01/2018 - 01/2008
5	Retinal Vein Occlusion 02/2017 - 12/2009
5	Vision Disorders (Hemeralopia) 02/2017 - 07/2015
5	Neovascular Glaucoma 01/2017 - 08/2010
5	Pathologic Neovascularization 01/2016 - 01/2008
4	Hypertension (High Blood Pressure) 01/2022 - 08/2003
4	Lymphoma (Lymphomas) 10/2017 - 08/2006
4	Ischemia 03/2017 - 01/2003
4	Corneal Neovascularization 07/2012 - 07/2003
3	Hypoxia (Hypoxemia) 04/2016 - 05/2004
3	Wounds and Injuries (Trauma) 07/2015 - 05/2011
3	Atrophy 05/2015 - 04/2007
3	Necrosis 11/2013 - 02/2011
3	Starvation 12/2011 - 06/2008
2	Neoplasm Metastasis (Metastasis) 01/2017 - 11/2005
2	Diabetes Mellitus 01/2017 - 01/2016
2	Myopia 01/2017 - 05/2015
2	Vascular Diseases (Vascular Disease) 01/2016 - 03/2012
2	Prodromal Symptoms 12/2012 - 12/2008
2	Ocular Hypertension (Glaucoma, Suspect) 09/2012 - 05/2011

Drug/Important Bio-Agent (IBA)

46	Retinaldehyde (Retinal)IBA 01/2022 - 03/2002
25	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2003
11	Ranibizumab (Lucentis)FDA Link 01/2021 - 06/2012
11	CytokinesIBA 03/2018 - 11/2005
10	PeriostinIBA 12/2017 - 07/2011
9	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2019 - 02/2003
8	Bevacizumab (Avastin)FDA Link 01/2017 - 08/2010
7	afliberceptIBA 05/2021 - 03/2015
7	Interleukin-6 (Interleukin 6)IBA 03/2018 - 04/2009
6	Interleukin-8 (Interleukin 8)IBA 03/2018 - 11/2003
6	pigment epithelium-derived factorIBA 03/2012 - 11/2008
6	Triamcinolone (Aristocort)FDA Link 01/2012 - 06/2002
5	Indocyanine Green (Cardio-Green)FDA LinkGeneric 03/2018 - 03/2003
5	Infliximab (Remicade)FDA Link 03/2018 - 09/2010
4	Pharmaceutical PreparationsIBA 05/2017 - 09/2007
4	Oxygen (Dioxygen)IBA 01/2016 - 08/2013
4	SolutionsIBA 01/2016 - 06/2002
4	Coloring Agents (Dyes)IBA 01/2014 - 03/2003
4	coomassie Brilliant BlueIBA 10/2013 - 07/2006
4	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2003
3	AntioxidantsIBA 10/2019 - 01/2013
3	Therapeutic UsesIBA 03/2017 - 09/2013
3	SteroidsIBA 01/2017 - 09/2012
3	Peptides (Polypeptides)IBA 12/2016 - 02/2008
3	interstitial retinol-binding proteinIBA 12/2016 - 02/2008
3	Retinal Pigments (Pigments, Visual)IBA 11/2016 - 04/2007
3	TenascinIBA 11/2016 - 01/2016
3	Interleukin-10 (Interleukin 10)IBA 11/2015 - 03/2011
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2015 - 09/2003
3	AntibodiesIBA 07/2015 - 07/2003
3	pegaptanib (Macugen)FDA Link 05/2015 - 09/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013 - 05/2004
3	ChemokinesIBA 01/2013 - 09/2003
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2008 - 07/2003
3	Messenger RNA (mRNA)IBA 07/2008 - 01/2003
2	K-115IBA 01/2020 - 04/2016
2	Purinergic P2X7 ReceptorsIBA 05/2018 - 01/2013
2	IntegrinsIBA 03/2017 - 11/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 09/2007
2	Protein Kinases (Protein Kinase)IBA 04/2016 - 11/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 07/2011
2	Glial Fibrillary Acidic ProteinIBA 01/2016 - 07/2015
2	LigandsIBA 11/2015 - 01/2013
2	FibrinIBA 04/2014 - 10/2011
2	dorzolamide (Trusopt)FDA LinkGeneric 09/2013 - 06/2012
2	Adenosine Triphosphate (ATP)IBA 01/2013 - 12/2011

Therapy/Procedure

36	Vitrectomy 10/2020 - 03/2002
20	Therapeutics 01/2020 - 01/2007
17	Lasers (Laser) 06/2019 - 11/2005
11	Intravitreal Injections 01/2017 - 06/2002
6	Light Coagulation 10/2016 - 07/2002
4	Injections 07/2019 - 06/2012
3	Trabeculectomy (Trabeculoplasty) 04/2014 - 08/2010
3	Cautery 01/2008 - 07/2003
2	Photochemotherapy (Photodynamic Therapy) 05/2021 - 01/2019
2	Capsulorhexis 09/2020 - 07/2015
2	Radiotherapy 01/2017 - 10/2016
2	Posterior Capsulotomy 05/2016 - 07/2015
2	Vitreoretinal Surgery 01/2013 - 10/2008
2	Ligation 01/2013 - 05/2002